Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-004452

General Counsel and Secretary sold 27,500 shares at an average $204.94 ($5,635,944)

  • General Counsel and Secretary acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Option exercise +27,500 $51.49 $1,415,975 49,931 D
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Sale −6,785 $203.58 $1,381,290 43,146 D
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Sale −7,818 $204.40 $1,597,999 35,328 D
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Sale −8,997 $205.60 $1,849,783 26,331 D
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Sale −1,800 $206.05 $370,890 24,531 D
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Sale −2,100 $207.61 $435,981 22,431 D
Derivatives
KASINGER JAMES R. General Counsel and Secretary 2021-01-19 Option exercise · Stock Option (right to buy) −27,500 12,500 D
Open-market sales · 27,500 sh · avg $204.94 · $5,635,944
Loading xslF345X03/doc4.xml…